IDYA stock results show that IDEAYA Biosciences missed analyst estimates for earnings per share the second quarter of 2024. More
Articles
BEAM Stock Earnings: Beam Therapeutics Beats EPS, Misses Revenue for Q2 2024
BEAM stock results show that Beam Therapeutics beat analyst estimates for earnings per share but missed on revenue for the second quarter of 2024. More
MNDO Stock Earnings: MIND C.T.I. Reported Results for Q2 2024
MIND C.T.I. just reported results for the second quarter of 2024. More
NMRA Stock Earnings: Neumora Therapeutics Meets EPS for Q2 2024
NMRA stock results show that Neumora Therapeutics met analyst estimates for earnings per share the second quarter of 2024. More
UNICY Stock Earnings: Unicharm Beats EPS for Q2 2024
UNICY stock results show that Unicharm beat analyst estimates for earnings per share the second quarter of 2024. More
OMGA Stock Earnings: Omega Therapeutics Beats EPS, Beats Revenue for Q2 2024
OMGA stock results show that Omega Therapeutics beat analyst estimates for earnings per share and beat on revenue for the second quarter of 2024. More
PTGX Stock Earnings: Protagonist Therapeutics Beats EPS, Misses Revenue for Q2 2024
PTGX stock results show that Protagonist Therapeutics beat analyst estimates for earnings per share but missed on revenue for the second quarter of 2024. More
